This company has been marked as potentially delisted and may not be actively trading. Five Prime Therapeutics (FPRX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock FPRX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Interim award has Prime Therapeutics paying more than $10 million to California-based pharmacyFebruary 2, 2025 | startribune.comSPlay Five Card Draw Online for Free | Yahoo! GamesAugust 9, 2024 | yahoo.comCMMB Chemomab Therapeutics Ltd.March 28, 2024 | seekingalpha.com33+ best October Prime Day deals you can still shop right nowOctober 15, 2023 | nbcnews.comNK Cell Therapy Pipeline, Clinical Trials Studies, Emerging Drugs, and FDA Approvals 2023 (Updated)October 11, 2023 | benzinga.comThe Giants’ prime time TV demons are haunting them nowOctober 3, 2023 | nypost.comNWhat Is The Prime Rate Today?August 3, 2023 | forbes.comWant $5? Amazon Prime members can get $5 off a $50 Amazon eGift Card right nowJuly 23, 2023 | usatoday.comPrime Therapeutics Hires New CEO To Lead Pharmacy Benefit Combination With MagellanRxJuly 5, 2023 | forbes.comGet ready for Amazon Prime Day 2023 with Prime membership discounts available nowJuly 2, 2023 | usatoday.comPrime Therapeutics announces Mostafa Kamal as presidentMarch 29, 2023 | benzinga.comPrime Therapeutics and Magellan Rx to present seven managed care pharmacy research studies at AMCP conferenceMarch 18, 2023 | finance.yahoo.com2023-2029 Cystic Fibrosis (CF) Therapeutics Market Size and Porters Five Forces Analysis | Survey Report by Absolute ReportsMarch 1, 2023 | marketwatch.comMicrobiome Therapeutics Market 2022 Expected to Reach Significant Rate by 2025October 27, 2022 | marketwatch.comOral Covid vaccine developer nails down Peninsula spaceSeptember 22, 2021 | feeds.bizjournals.comFive Prime Therapeutics, Inc. Common Stock (FPRX)August 3, 2021 | nasdaq.com Get Five Prime Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address FPRX Media Mentions By Week FPRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FPRX News Sentiment▼0.001.00▲Average Medical News Sentiment FPRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FPRX Articles This Week▼00▲FPRX Articles Average Week Get Five Prime Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for FPRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MOR News CALT News ZYME News CMRX News CDMO News MBX News RVNC News CKPT News AVTE News TSVT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FPRX) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Five Prime Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Five Prime Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FPRX Stock Alerts